Sandra Shpilberg

Managing Director


Sandra Shpilberg

Sandra’s entrepreneurial spirit and experience in the pharma and biopharmaceutical industries led her to develop a breakthrough digital patient identification technology designed to accelerate drug development and commercialization for biopharmaceutical companies. The product currently serves more than 40 companies in helping to accelerate clinical trial enrollment in rare diseases and oncology.

Medical Marketing & Media named her a Top 40 Healthcare Transformer, and in 2018, she was a featured speaker at SXSW.

Originally from Uruguay, Sandra speaks fluent Spanish and brings a global approach to her work.

She holds an MBA in marketing and entrepreneurial management from the Wharton School at the University of Pennsylvania.


Patient Journey, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Events with Sandra Shpilberg

Articles by Sandra Shpilberg

Eight Powerful Strategies Business Leaders Can Build on for Success

Sandra Shpilberg shared insight in a Silicon Valley Business Journal’s article focused on “Eight Powerful Strategies Business Leaders Can Build on for Success.” The article is part of the Journal’s invite-only Leadership Trust panel of influential business leaders, executives and entrepreneurs. Sandra’s advice is to develop a singular focus: “Single deep focus is the habit […]

Wearables In Clinical Trials

Pharma Voice Magazine features Sandra Shpilberg from Seeker Health, an EVERSANA company, in their March 2019 issue. The topic is “Wearables in Clinical Trial”.  The article discusses how wearables are improving the clinical trial experience for patients and satisfying the need to collect data for real-world use studies. And experts agree: future drug development will be […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.